Skip to search formSkip to main contentSkip to account menu

vastatin

Known as: vastatins 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Collagen Type VIII

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Pharmacokinetics and exploratory efficacy biomarkers of bococizumab, an anti-PCSK9 monoclonal antibody, in hypercholesterolemic Japanese subjects
Objective: Bococizumab, a monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9, has been shown to reduce… 
2009
2009
Recombinant adeno-associated virus serotype 2 (rAAV2)-An efficient vector for gene delivery in condylar cartilage, glenoid fossa and TMJ disc in an experimental study in vivo.
Highly Cited
1999
Highly Cited
1999
Ator vastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin
1999
1999
High lovastatin doses combined with hypercholesterolemic diet induce hepatic damage and are lethal to the CD-1 mouse.
Review
1998
Review
1998
Preclinical review of cerivastatin sodium--a step forward in HMG-CoA reductase inhibition.
1997
1997
Vastatins Inhibit Tissue Factor in Cultured Human Macrophages
We examined the effect of fluvastatin, the first entirely synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor… 
Review
1997
Review
1997
Pharmacological Control of Phagocyte Function: Inhibition of Cholesterol Accumulation
Phagocytes play a major role in several diseases. In particular mononuclear phagocyte-derived foam cells have a prominent role in… 
1996
1996
Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins
Objective To determine the effects of vastatins on the contraction of rat aortic rings and to assess their effects on calcium… 
1993
1993
Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin.
The influence of the 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitors pravastatin and simvastatin on lens… 
1992
1992
Combination drug therapy in the treatment of severe hyperlipidaemia
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)